2018 AIChE Annual Meeting

Session: Immunotherapy Applications

Immunotherapy has emerged as a major breakthrough in modern medicine, offering novel treatment options to otherwise incurable diseases such as metastatic cancer and post-transplant viral infections. This session will focus on engineered protein and cell-based immunotherapy. Topics of interest include but are not limited to antibody therapy, adoptive T-cell therapy, natural killer (NK) cell therapy, and engineered cytokines and other proteins that interface with the immune system.

Chair

Yvonne Y. Chen, University of California, Los Angeles

Co-Chair

Wilson Wong, Boston University

Presentations

12:30 PM

01:05 PM

01:23 PM

Everett Stone, John Blazeck, Kendra Garrison, George Georgiou, Christos Karamitros, Catrina Somody, Ahlam Qerqez, Kyle Ford

01:48 PM

Dana N. Thornlow, Matthew DeLisa, Emily C. Cox, Michaela A. Jones

02:06 PM

Xiaofei Wang, Rui Zhang, Dylan Weir, Caitlin Leeper, Andrew Greenwald, Bret Ulery

02:24 PM